Antibody: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 4: | Line 4: | ||
For Anti-HIV Fab see [[Human Fab PG16]]<br /> | For Anti-HIV Fab see [[Human Fab PG16]]<br /> | ||
For Anti-VEGF Fab see [[Bevacizumab]] (Avastin)<br /> | For Anti-VEGF Fab see [[Bevacizumab]] (Avastin)<br /> | ||
For Anti-factor IX Fab see [[Conformation-specific anti-Factor IX antibodies]] | For Anti-factor IX Fab see [[Conformation-specific anti-Factor IX antibodies]]. | ||